Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2004-6-2
pubmed:abstractText
We estimated the prevalence and prognostic significance of neuroendocrine (NE) cells in a series of 208 resection specimens containing gastroesophageal junction (GEJ) adenocarcinomas, with 56 specimens containing Barrett's mucosa. Immunohistochemically, chromogranin A (CGA) was positive in 49% (102/208) of GEJ adenocarcinomas and in 68% (38/56) of Barrett's mucosas. CGA in GEJ tumors correlated with pTNM stage. CGA in Barrett correlated with pTNM stage and tumor grade of the adjacent carcinoma. Patients with CGA in Barrett had better survival than patients without CGA in Barrett, with 5-year survival percentages of 56% and 9%, respectively. In multi-variate analysis, CGA in Barrett was an independent prognostic factor for survival after surgery. Therefore CGA in Barrett adjacent to GEJ adenocarcinoma might be helpful in the assessment of patient outcome.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1066-8969
pubmed:author
pubmed:issnType
Print
pubmed:volume
12
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
117-25
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:15173916-Adenocarcinoma, pubmed-meshheading:15173916-Adult, pubmed-meshheading:15173916-Aged, pubmed-meshheading:15173916-Aged, 80 and over, pubmed-meshheading:15173916-Barrett Esophagus, pubmed-meshheading:15173916-Chromogranin A, pubmed-meshheading:15173916-Chromogranins, pubmed-meshheading:15173916-Esophageal Neoplasms, pubmed-meshheading:15173916-Esophagogastric Junction, pubmed-meshheading:15173916-Female, pubmed-meshheading:15173916-Fluorescent Antibody Technique, Indirect, pubmed-meshheading:15173916-Gastric Mucosa, pubmed-meshheading:15173916-Humans, pubmed-meshheading:15173916-Immunoenzyme Techniques, pubmed-meshheading:15173916-Male, pubmed-meshheading:15173916-Middle Aged, pubmed-meshheading:15173916-Neoplasm Staging, pubmed-meshheading:15173916-Neurosecretory Systems, pubmed-meshheading:15173916-Survival Rate, pubmed-meshheading:15173916-Tumor Markers, Biological
pubmed:year
2004
pubmed:articleTitle
Neuroendocrine in Barrett's mucosa and adenocarcinomas of the gastroesophageal junction.
pubmed:affiliation
Department of Surgery, Josephine Nefkens Institute, University Medical Center Rotterdam, The Netherlands.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't